Patents Assigned to Universita di Napoli Federico II
  • ECTOPICALLY EXPRESSED TRANSCRIPTION FACTORS AND USES THEREOF
    Publication number: 20240263191
    Abstract: The present invention relates to a nucleic acid construct allowing to drives the expression of a transcription factor in rod cells or cone cells thereby silencing the expression of a gene which mutated form is responsible for a retinal dystrophy and its medical use, relative expression vector, host cell, viral particle and pharmaceutical composition.
    Type: Application
    Filed: December 21, 2018
    Publication date: August 8, 2024
    Applicant: UNIVERSITA DI NAPOLI FEDERICO II
    Inventors: Enrico Maria SURACE, Salvatore BOTTA, Elena MARROCCO, Nicola DE PRISCO
  • Methods for treating heart failure with a TRKB agonist
    Patent number: 11235029
    Abstract: The present invention relates to compositions and methods for the treatment of heart failure.
    Type: Grant
    Filed: March 9, 2018
    Date of Patent: February 1, 2022
    Assignees: Temple University-Of The Commonwealth System of Higher, Education Johns Hopkins Technology Ventures, Universita di Napoli Federico II
    Inventors: Alessandro Cannavo, Ning Feng, Giuseppe Rengo, Nazareno Paolocci, Walter J. Koch
  • Injectable hydrogels from microfiber suspensions
    Patent number: 10617791
    Abstract: Provided is a hydrogel. The hydrogel includes a liquid and a plurality of microfibers suspended in the liquid as an entangled network. The entangled network includes physically entangled microfibers that are mechanically interlocked.
    Type: Grant
    Filed: May 31, 2016
    Date of Patent: April 14, 2020
    Assignees: THE TRUSTEES OF PRINCETON UNIVERSITY, UNIVERSITÀ DI NAPOLI “FEDERICO II” DIPARTIMENTO DI INGEGNERIA CHIMICA, DEI MATERIALI E DELLA PRODUZIONE INDUSTRIALE
    Inventors: Janine K. Nunes, Antonio Perazzo, Stefano Guido, Howard A. Stone
  • Control of pain with endogenous cannabinoids
    Patent number: 6656972
    Abstract: Novel pharmaceutical therapeutic compositions and methods for using same for the treatment of pain experienced by an individual are provided. The compositions contain at least one member selected from among anandamide and palmitylethanolamide.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: December 2, 2003
    Assignees: Neurosciences Research Foundation, Inc., Universita di Napoli Federico II
    Inventors: Antonio Calignano, Giovanna La Rana, Andrea Guiffrida, Daniele Piomelli